Application of a zwitterionic hydrogel in the preparation of diabetic skin repair materials

Through the preparation of zwitterionic hydrogel, the balance of immune cells is regulated, and the problem of difficulty in healing the skin wounds of diabetic patients is solved, significant anti-inflammatory and repair effects are achieved, and the drug resistance problem is avoided by drug addition, providing a suitable solution. Soft skin dressing for people with diabetes.

CN117599237BActive Publication Date: 2024-11-26PEKING UNIV SCHOOL OF STOMATOLOGY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311538579.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-11-17
Publication Date
2024-11-26
Estimated Expiration
2043-11-17

AI Technical Summary

Technical Problem

Due to the decreased immune function and abnormal blood sugar in the skin wounds of diabetic patients, it is difficult to heal themselves. The existing hydrogel dressings require a variety of drugs to achieve repair functions, but they are prone to drug resistance and are difficult to design simple dressings with excellent skin repair functions.

Method used

Zwitterionic hydrogel is used as a diabetic skin repair material, and the quantitative balance of macrophages and neutrophils is regulated through the combination of specific monomers, crosslinkers and initiators, to achieve anti-inflammatory effects, and prepared through polymerization reaction Hydrogel with soft texture, suitable for use as a skin dressing.

Benefits of technology

It significantly improves the healing speed and repair effect of skin wounds in diabetic rats, has good anti-inflammatory effects, avoids the drug resistance problems caused by drug addition, and is soft in texture suitable as a skin dressing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117599237B_ABST
    Figure CN117599237B_ABST
Patent Text Reader

Abstract

The present invention provides an application of a zwitterionic hydrogel in the preparation of a diabetic skin repair material, belonging to the technical field of biomedical materials. The raw materials for preparing the zwitterionic hydrogel of the present invention include a first monomer, a second monomer, a crosslinking agent, an initiator and a solvent; the present invention uses a zwitterionic hydrogel of a specific composition as a diabetic skin repair material, and the zwitterionic hydrogel used has a significant anti-inflammatory effect on diabetic rat skin wounds, can significantly improve the healing speed of diabetic rat skin wounds, and improve the repair effect of diabetic skin damage sites; and the zwitterionic hydrogel has a simple composition and does not require the addition of additional drugs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of biomedical materials, and in particular to application of a zwitterionic hydrogel in preparing a diabetic skin repair material. Background Art

[0002] Skin injury is one of the most common external traumas in life. Generally speaking, a healthy body has a certain self-repair ability, and can stop bleeding and heal relatively minor injuries in a short period of time. However, for some patients with underlying diseases, especially diabetic patients, due to various reasons, including decreased immune function, abnormal glucose metabolism leading to lack of tissue factor, increased blood sugar levels leading to neurovascular disorders, and high blood sugar concentrations inhibiting leukocyte phagocytosis and making it easier for bacteria to breed, the skin wounds of diabetic patients are more susceptible to infection and inflammation, and even minor injuries cannot heal themselves. Therefore, hand and foot ulcers caused by skin injuries are one of the most common and serious complications of diabetic patients. Unlike healthy bodies, diabetic patients' skin wounds urgently need special treatments to control inflammation and promote skin repair.

[0003] At present, the treatment for diabetic skin wound repair mainly focuses on controlling blood sugar, anti-infection, regulating metabolism, revascularization, nutritional support, etc. Non-surgical treatment methods include palliative debridement, wound medication, wound dressings, etc. Among them, wound dressings, especially hydrogel dressings, have complex functions such as sterilization, active adsorption, drainage of exudate, and anti-adhesion, which are convenient for patients to use by themselves. It is one of the most promising dressings among the many diabetic skin repair materials. However, most of the hydrogel dressings currently developed need to load a variety of anti-inflammatory drugs, growth factors and other additives in the gel to achieve the corresponding specific functions, which are prone to drug resistance. Therefore, it is still challenging to design hydrogel dressings with simple composition but excellent skin repair function. Summary of the invention

[0004] The purpose of the present invention is to provide an application of a zwitterionic hydrogel in the preparation of a diabetic skin repair material, so as to improve the repair effect of diabetic skin damage sites.

[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0006] The present invention provides an application of a zwitterionic hydrogel in preparing a diabetic skin repair material, wherein the raw materials for preparing the zwitterionic hydrogel include a first monomer, a second monomer, a crosslinking agent, an initiator and a solvent;

[0007] Taking the total amount of the raw materials for preparation as 100%, the total mass percentage of the first monomer and the second monomer in the raw materials for preparation is 5-30%, the first monomer accounts for 10-90% of the total mass fraction of the first monomer and the second monomer, the mass of the cross-linking agent is 0.5-1.0% of the total mass of the first monomer and the second monomer; the mass of the initiator is 0.5-1.0% of the total mass of the first monomer and the second monomer, and the remainder is the solvent.

[0008] Preferably, the first monomer includes one or more of dimethylamine oxide, sulfobetaine, carboxybetaine and phosphobetaine.

[0009] Preferably, the second monomer includes one or more of methacrylated gelatin, polyvinyl alcohol, acrylamide and N-isopropylacrylamide.

[0010] Preferably, the crosslinking agent includes N,N-methylenebisacrylamide and / or ethylene glycol diacrylate.

[0011] Preferably, the initiator comprises photoinitiator LAP type, photoinitiator 1173 type, photoinitiator 2959 type or ammonium persulfate.

[0012] Preferably, the solvent includes physiological saline or PBS buffer; the concentration of sodium chloride in the physiological saline is 0.9wt%, and the pH value of the PBS buffer is 7-7.5.

[0013] Preferably, the method for preparing the zwitterionic hydrogel comprises the following steps:

[0014] The first monomer, the second monomer, the crosslinking agent, the initiator and the solvent are mixed, and the obtained precursor solution is polymerized to obtain the zwitterionic hydrogel.

[0015] Preferably, when the initiator is a photoinitiator, the polymerization reaction is carried out under ultraviolet light with a wavelength of 365 to 402 nm for 60 to 120 seconds to obtain a zwitterionic hydrogel.

[0016] Preferably, when the initiator is ammonium persulfate, the polymerization reaction is carried out at 50-60° C. for 1-2 hours to obtain a zwitterionic hydrogel.

[0017] The present invention uses a zwitterionic hydrogel with a specific composition as a diabetic skin repair material. When the zwitterionic hydrogel is used as an extracellular matrix, it can regulate the quantitative balance of macrophages and neutrophils. This immune cell subpopulation can synergistically enhance the anti-inflammatory effect. Therefore, the zwitterionic hydrogel has a good anti-inflammatory effect and has a significant anti-inflammatory effect on the skin wounds of diabetic rats. It can significantly increase the healing speed of the skin wounds of diabetic rats and improve the repair effect of diabetic skin damage sites. It is more suitable for diabetic patients with skin damage that is extremely prone to inflammation and ulcers and cannot heal itself.

[0018] The zwitterionic hydrogel used in the present invention has a simple composition, does not need to add additional drugs, and does not need to consider the problem of drug resistance.

[0019] Compared with the existing high-strength hydrogel dressings, the zwitterionic hydrogel used in the present invention has a soft texture, good contact effect with the wound, a tensile modulus of 30 to 45 kPa, and a compression modulus of 40 to 70 kPa, and is suitable for use as a skin dressing. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 The microscopic morphology of the hydrogels prepared in Examples 1 to 4 and Comparative Examples 1 to 4;

[0021] Figure 2 This is a diagram showing the repair effect of the hydrogels prepared in Examples 1 to 2 and Comparative Example 1 on the skin wounds of diabetic rats;

[0022] Figure 3 This is a diagram showing the results of quantitative analysis of the wound areas of the hydrogels prepared in Examples 1 to 2 and Comparative Example 1 on the skin wounds of diabetic rats. DETAILED DESCRIPTION

[0023] The invention provides an application of a zwitterionic hydrogel in preparing a diabetic skin repair material. The raw materials for preparing the zwitterionic hydrogel include a first monomer, a second monomer, a crosslinking agent, an initiator and a solvent. Taking the total amount of the raw materials as 100%, the total mass percentage of the first monomer and the second monomer in the raw materials is 5-30%, the first monomer accounts for 10-90% of the total mass fraction of the first monomer and the second monomer, the mass of the crosslinking agent is 0.5-1.0% of the total mass of the first monomer and the second monomer; the mass of the initiator is 0.5-1.0% of the total mass of the first monomer and the second monomer, and the remainder is the solvent.

[0024] In the present invention, the first monomer preferably includes one or more of dimethylamine oxide, sulfobetaine, carboxybetaine and phosphobetaine; when the first monomer is two or more of the above, the present invention has no special limitation on the ratio of different types of monomers, which can be adjusted according to actual needs.

[0025] In the present invention, the structural formula of the first monomer (having both positive and negative charges) includes:

[0026]

[0027] In the present invention, the second monomer preferably includes one or more of methacrylated gelatin, polyvinyl alcohol, acrylamide and N-isopropylacrylamide; when the second monomer is two or more of the above, the present invention has no special restrictions on the ratio of different types of monomers, and can be adjusted according to actual needs. The second monomer of the present invention has no biological toxicity, and the second monomer is used to provide better mechanical support for the zwitterionic hydrogel, improve the mechanical properties of the zwitterionic hydrogel, and make it more suitable for use as a skin dressing.

[0028] In the present invention, the total mass percentage of the first monomer and the second monomer in the preparation raw material is preferably 5-30%, more preferably 10-20%; the first monomer accounts for 10-90% of the total mass fraction of the first monomer and the second monomer, more preferably 20-50%, and further preferably 27-40%.

[0029] In the present invention, the crosslinking agent preferably includes N,N-methylenebisacrylamide and / or ethylene glycol diacrylate; the mass of the crosslinking agent is preferably 0.5-1.0% of the total mass of the first monomer and the second monomer, and more preferably 0.6-0.8%.

[0030] In the present invention, the initiator preferably includes photoinitiator LAP type, photoinitiator 1173 type, photoinitiator 2959 type or ammonium persulfate; the mass of the initiator is preferably 0.5-1.0% of the total mass of the first monomer and the second monomer, and more preferably 0.6-0.8%.

[0031] In the present invention, the solvent preferably includes physiological saline or PBS buffer; the concentration of sodium chloride in the physiological saline is preferably 0.9 wt %, and the pH value of the PBS buffer is preferably 7 to 7.5.

[0032] Based on the total amount of the raw materials for preparation being 100%, the amount of the solvent used is the remainder excluding the first monomer, the second monomer, the crosslinking agent and the initiator.

[0033] In the present invention, the method for preparing the zwitterionic hydrogel preferably comprises the following steps:

[0034] The first monomer, the second monomer, the crosslinking agent, the initiator and the solvent are mixed, and the obtained precursor solution is polymerized to obtain the zwitterionic hydrogel.

[0035] The present invention has no special limitation on the mixing of the first monomer, the second monomer, the crosslinking agent, the initiator and the solvent, and the mixing can be carried out according to the process well known in the art.

[0036] In the present invention, when the initiator is a photoinitiator, the polymerization reaction is preferably carried out under ultraviolet light with a wavelength of 365 to 402 nm for 60 to 120 seconds to obtain the zwitterionic hydrogel.

[0037] In the present invention, when the initiator is ammonium persulfate, the polymerization reaction is preferably carried out at 50-60° C. for 1-2 hours to obtain a zwitterionic hydrogel.

[0038] In the present invention, when the second monomer includes polyvinyl alcohol, after completing the polymerization reaction, the present invention preferably adopts a freeze-thaw method (freeze-thaw cycle) to prepare the zwitterionic hydrogel; the present invention has no special limitation on the specific process of the freeze-thaw method, and it can be carried out according to the process well known in the art.

[0039] The present invention has no particular limitation on the specific method for preparing the diabetic skin repair material with the zwitterionic hydrogel, and the zwitterionic hydrogel can be used as the repair material according to methods well known in the art.

[0040] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.

[0041] The specifications of the raw materials used in the examples of the present invention are shown in Table 1.

[0042] Table 1 Specification information of raw materials used in the examples

[0043]

[0044]

[0045] Example 1

[0046] The preparation method of the zwitterionic hydrogel in this embodiment includes the following components by mass percentage:

[0047]

[0048] The specific preparation steps are:

[0049] (1) 0.1 g of dimethylamine oxide, 0.9 g of methacrylated gelatin, 5 mg of LAP-type photoinitiator and 5 mg of N,N-methylenebisacrylamide crosslinker were added to 8.99 g of PBS buffer with a pH of 7 and dissolved by shaking at 60°C in the dark;

[0050] (2) The completely dissolved solution is injected into a mold and polymerized under a 402 nm ultraviolet lamp for 60 seconds to obtain a zwitterionic hydrogel dressing.

[0051] Example 2

[0052] The preparation method of the zwitterionic hydrogel in this embodiment includes the following components by mass percentage:

[0053]

[0054]

[0055] The specific preparation steps are:

[0056] (1) Add 0.4 g of sulfobetaine, 1.6 g of polyvinyl alcohol, 10 mg of 1173 photoinitiator and 10 mg of N,N-methylenebisacrylamide crosslinker to 7.98 g of normal saline and shake well in the dark;

[0057] (2) The completely dissolved solution was injected into a mold and polymerized under a 365 nm ultraviolet lamp for 60 seconds. The sample was then placed in a -18°C refrigerator and frozen for 12 hours, followed by thawing at room temperature for 1 hour. After completing three freeze-thaw cycles, a zwitterionic hydrogel was obtained.

[0058] Example 3

[0059] The preparation method of the zwitterionic hydrogel in this embodiment includes the following components by mass percentage:

[0060]

[0061] The specific preparation steps are:

[0062] (1) Add 2.7 g of carboxybetaine, 0.3 g of acrylamide, 30 mg of 2959 photoinitiator and 30 mg of ethylene glycol diacrylate crosslinker to 6.94 g of PBS buffer with a pH of 7.5 and shake well in the dark;

[0063] (2) The completely dissolved solution was injected into a mold and polymerized under a 365 nm ultraviolet lamp for 60 seconds to obtain a zwitterionic hydrogel.

[0064] Example 4

[0065] The preparation method of the zwitterionic hydrogel in this embodiment includes the following components by mass percentage:

[0066]

[0067]

[0068] The specific preparation steps are:

[0069] (1) Add 0.25 g of phosphobetaine, 0.25 g of N-isopropylacrylamide, 2.5 mg of ammonium persulfate and 2.5 mg of N,N-methylenebisacrylamide crosslinker to 9.495 g of normal saline and shake well to dissolve;

[0070] (2) The completely dissolved solution was injected into a mold, sealed, and polymerized in an oven at 50° C. for 1 h to obtain a zwitterionic hydrogel.

[0071] Comparative Example 1

[0072] The preparation method of the hydrogel in this comparative example comprises the following components by mass percentage:

[0073]

[0074] The specific preparation steps are:

[0075] (1) Add 1 g of methacrylated gelatin, 5 mg of LAP-type photoinitiator and 5 mg of N,N-methylenebisacrylamide crosslinker to 8.99 g of PBS buffer (pH 7) and dissolve at 60°C in a dark place under shaking;

[0076] (2) The completely dissolved solution was injected into a mold and polymerized under a 402 nm ultraviolet lamp for 60 seconds to obtain a hydrogel.

[0077] Comparative Example 2

[0078] The preparation method of the hydrogel in this comparative example comprises the following components by mass percentage:

[0079] Polyvinyl alcohol: 10%

[0080] Saline: 90%

[0081] The specific preparation steps are:

[0082] (1) Add 1 g of polyvinyl alcohol to 9 g of saline and stir for 1 h.

[0083] (2) The completely dissolved solution was injected into a mold, and the sample was placed in a -18°C refrigerator and frozen for 12 h, followed by thawing at room temperature for 1 h. After completing three freeze-thaw cycles, a hydrogel was obtained.

[0084] Comparative Example 3

[0085] The preparation method of the hydrogel in this comparative example comprises the following components by mass percentage:

[0086]

[0087] The specific preparation steps are:

[0088] (1) Add 1 g of acrylamide, 5 mg of 2959 photoinitiator and 5 mg of ethylene glycol diacrylate crosslinker to 8.99 g of PBS buffer with a pH of 7.5 and shake well in the dark;

[0089] (2) The completely dissolved solution was injected into a mold and polymerized under a 365 nm ultraviolet lamp for 60 seconds to obtain a hydrogel.

[0090] Comparative Example 4

[0091] The preparation method of the hydrogel in this comparative example comprises the following components by mass percentage:

[0092]

[0093] The specific preparation steps are:

[0094] (1) Add 1 g of N-isopropylacrylamide, 5 mg of ammonium persulfate and 5 mg of N,N-methylenebisacrylamide crosslinker to 8.99 g of normal saline and shake well in the dark;

[0095] (2) The completely dissolved solution was injected into a mold, sealed, and polymerized in an oven at 50° C. for 1 h to obtain a hydrogel.

[0096] Characterization and testing

[0097] 1) After freeze-drying the hydrogel using a freeze dryer, the microscopic morphology of the freeze-dried hydrogel was characterized using a scanning electron microscope. Figure 1 The microscopic morphology of the hydrogels prepared in Examples 1 to 4 and Comparative Examples 1 to 4, compared with Comparative Examples 1 to 4, the gels in Examples 1 to 4 have loose pores and larger pore sizes, are easy to maintain an aqueous environment, and are more conducive to material exchange when used as a dressing.

[0098] 2) Diabetic rat model: Diabetic rats were randomly divided into 3 groups (n=5), and the rats were anesthetized by intraperitoneal injection of 1% sodium pentobarbital, and then a circular wound with a diameter of 10 mm was made on the back.

[0099] Skin repair experiment: The three hydrogel dressings prepared in Examples 1 to 2 and Comparative Example 1 were applied to the skin wounds respectively and fixed with breathable tape. Afterwards, the rats were returned to the cage for feeding. The wounds were photographed and the dressings were changed after 3, 7, 11, and 14 days, and the changes in wound area were counted. Finally, the rats were euthanized by inhaling excessive CO2.

[0100] Different hydrogel dressings were applied to the skin defect sites of diabetic rats. The back of the experimental rats had a wound with a diameter of 10 mm. The hydrogel dressing had a diameter of 10 mm and a thickness of 2 mm. The dressings were changed on the 3rd, 7th, 11th and 14th days and the changes in wound area were counted to observe the skin repair effect. The results are shown in Figures 2-3 .

[0101] Figure 2 The repair effect of the hydrogels prepared in Examples 1 to 2 and Comparative Example 1 on the skin wounds of diabetic rats is shown in FIG. Figure 2 It can be seen that compared with Comparative Example 1, the skin regeneration effect in Examples 1 to 2 is better. After using the zwitterionic hydrogel dressing for 3, 7, 11 and 14 days, the inflammation is relieved, the new skin tissue increases, and the wound area is reduced.

[0102] Figure 3 The quantitative analysis results of the wound area of ​​the hydrogels prepared in Examples 1 to 2 and Comparative Example 1 on the skin wounds of diabetic rats are shown. The initial area (i.e., day 0) is taken as 100%, and the wound area at each dressing change is calculated as the relative wound area. Figure 3 It can be seen that compared with Comparative Example 1, the skin regeneration effect in Examples 1 to 2 is better, and the relative wound area is smaller after using the zwitterionic hydrogel dressing for 3, 7, 11 and 14 days.

[0103] The specific data of skin repair of Examples 1 to 4 and Comparative Examples 1 to 4 are shown in Table 2.

[0104] Table 2 Repair effects of different hydrogel dressings on skin damage in diabetic rats

[0105]

[0106]

[0107] As can be seen from Table 2, compared with Comparative Examples 1 to 4, the zwitterionic hydrogel dressings of Examples 1 to 4 have better repair effects, and the wound area is smaller under the same action time. After 14 days of action, the wound area is reduced to 22-28%, while the wound area of ​​Comparative Examples 1 to 4 is still 35-43%, indicating that the zwitterionic hydrogel used in the present invention can enhance the anti-inflammatory effect.

[0108] 4) The hydrogel was subjected to tensile and compression tests using a universal mechanical testing machine, where the tensile specimen was a dumbbell-shaped specimen (GB / T528-2009, type 4 specimen, with a length, width and thickness of 12×2×1 mm at the narrow part), and the compression specimen was a cylindrical specimen (with a diameter and height of 10 mm). The test speed was 50 mm / min, and three samples were tested in each group. The results are shown in Table 3.

[0109] Table 3 Mechanical properties of different hydrogel dressings

[0110]

[0111] It can be seen from Table 3 that the zwitterionic hydrogels in Examples 1 to 4 are soft in texture, have a tensile modulus of 30 to 45 kPa, and a compression modulus of 40 to 70 kPa, and are suitable for use as skin dressings.

[0112] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. Application of a zwitterionic hydrogel in the preparation of diabetic skin repair materials, characterized in that: The raw materials for preparing the zwitterionic hydrogel include a first monomer, a second monomer, a crosslinking agent, an initiator and a solvent; Taking the total amount of the raw materials for preparation as 100%, the total mass percentage of the first monomer and the second monomer in the raw materials for preparation is 5-30%, the first monomer accounts for 10-90% of the total mass fraction of the first monomer and the second monomer, the mass of the crosslinking agent is 0.5-1.0% of the total mass of the first monomer and the second monomer; the mass of the initiator is 0.5-1.0% of the total mass of the first monomer and the second monomer, and the remainder is the solvent; The first monomer includes one or more of dimethylamine oxide, sulfobetaine, carboxybetaine and phosphobetaine; The second monomer includes one or more of methacrylated gelatin, acrylamide and N-isopropylacrylamide.

2. The use according to claim 1, characterized in that: The crosslinking agent includes N,N-methylenebisacrylamide and / or ethylene glycol diacrylate.

3. The use according to claim 1, characterized in that: The initiator includes photoinitiator LAP type, photoinitiator 1173 type, photoinitiator 2959 type or ammonium persulfate.

4. The use according to claim 1, characterized in that: The solvent includes physiological saline or PBS buffer; the concentration of sodium chloride in the physiological saline is 0.9wt%, and the pH value of the PBS buffer is 7-7.

5.

5. The use according to claim 1, characterized in that: The preparation method of the zwitterionic hydrogel comprises the following steps: The first monomer, the second monomer, the crosslinking agent, the initiator and the solvent are mixed, and the obtained precursor solution is polymerized to obtain the zwitterionic hydrogel.

6. The use according to claim 5, characterized in that: When the initiator is a photoinitiator, the polymerization reaction is carried out for 60 to 120 seconds under ultraviolet light with a wavelength of 365 to 402 nm to obtain a zwitterionic hydrogel.

7. The use according to claim 5, characterized in that: When the initiator is ammonium persulfate, the polymerization reaction is carried out at 50-60° C. for 1-2 hours to obtain a zwitterionic hydrogel.